Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 15.06.2026 1 Acta Cytol 1 AJR Am J Roentgenol 1 Am J Epidemiol 1 Am J Surg 1 Ann Surg 3 Ann Surg Oncol 3 BMC Cancer 1 Breast Cancer 2 Breast Cancer (Auckl) 1 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 6 Breast Cancer Res Treat 2 Cancer 4 Cancer Cell 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Lett 1 Cancer Res 3 Clin Breast Cancer 1 Eur J Cancer 1 Eur J Surg Oncol 1 Eur Radiol 2 Histopathology 1 Int J Radiat Oncol Biol Phys 1 J Biol Chem 1 J Clin Oncol 2 J Natl Cancer Inst 1 Lancet Oncol 4 NPJ Breast Cancer 5 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Cytol

1. TELES AE, Schmitt FC
   Cytological Assessment of Paediatric Breast Lesions: A Systematic Review.
   Acta Cytol. 2026;70:299-309.
   PubMed         Abstract available
   
   

   
   AJR Am J Roentgenol

2. SEELY JM, Yaffe MJ, Warren L, Gordon PB, et al
   TMIST Lead-In Randomized Trial of Breast Tomosynthesis Versus Digital Mammography: Results in Women Ineligible for the Full TMIST Trial Due to Age (40-44 or >/= 74 Years Old).
   AJR Am J Roentgenol. 2026 Jan 28. doi: 10.2214/AJR.25.34244.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

3. STEVENS VL, Priest J, Wilkerson J, D'Aloisio AA, et al
   Weight cycling and cancer risk in the Sister Study.
   Am J Epidemiol. 2026;195:1786-1795.
   PubMed         Abstract available
   
   

   
   Am J Surg

4. EGBERT LK, Kosiorek HE, Cronin P, Billar J, et al
   Outpatient mastectomy: ERAS(R) and same-day discharge as a viable option in the elderly.
   Am J Surg. 2026;258:117002.
   PubMed         Abstract available
   
   

   
   Ann Surg

5. CHEN J, Gabay A, Boe LA, Shammas RL, et al
   Machine Learning Accurately Predicts Patient-reported Outcomes 1 Year After Breast Reconstruction.
   Ann Surg. 2026;284:176-183.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

6. JENG A, Morgan M, Willey SC, Chawla A, et al
   Recent Trends in Whole-Breast Irradiation Versus Partial-Breast Irradiation in Ductal Carcinoma in situ with Breast-Conserving Surgery 2011-2021: A National Cancer Database Study.
   Ann Surg Oncol. 2026;33:6367-6374.
   PubMed         Abstract available
   
   
7. CORSI F, Pelizzola M, Bossi D, Zanella V, et al
   A Prospective Randomized Trial Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed Localization for the Localization of Nonpalpable Breast Lesions: Analysis of Surgical Outcomes, Patient's Perception, and Costs.
   Ann Surg Oncol. 2026;33:6403-6413.
   PubMed         Abstract available
   
   
8. JEON JH, Higgins MG, Durden J, Adams M, et al
   Attitudes and Perspectives on Shared Decision Making Among Breast Surgical Oncologists: A Qualitative Study.
   Ann Surg Oncol. 2026;33:6433-6443.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. SHI Y, Fu P, Wang Y, Li Y, et al
   Real-world effectiveness of mecapegfilgrastim for prophylaxis in patients with breast cancer receiving 2-weekly and 3-weekly chemotherapy in China.
   BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16280.
   PubMed         Abstract available
   
   
10. WEI Y, Qi Y, Ge H, Zeng C, et al
    Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer.
    BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16230.
    PubMed         Abstract available
    
    
11. YI C, Xu T, You R, Zhang Q, et al
    Ultrasound-based predictive models for response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2026 Jun 11. doi: 10.1186/s12885-026-16330.
    PubMed         Abstract available
    
    

    
    Breast Cancer

12. IWATANI T, Masuda N, Saji S, Yamaguchi T, et al
    Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.
    Breast Cancer. 2026 Jun 10. doi: 10.1007/s12282-026-01876.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Auckl)

13. NEGRET MA, Grajales D, Gonzalez V, Lopez S, et al
    Bioimpedance Spectroscopy as a Triage-Support Tool for Breast Cancer Prioritization in a Low- and Middle-Income Country: A Commentary on Published Evidence From a Bioimpedance-Based Device.
    Breast Cancer (Auckl). 2026;20:11782234261457498.
    PubMed         Abstract available
    
    
14. AMIRI HEZAVE Y, Najafi R, Amini R, Shojaeian A, et al
    Spiegelmer Aptamers: Innovative Approach in Breast Cancer.
    Breast Cancer (Auckl). 2026;20:11782234261456036.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

15. CHEN YC, Cheng MC, Chen PH, Chung CH, et al
    Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan.
    Breast Cancer (Dove Med Press). 2026;18:595563.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

16. BARNARD ME, Xu NN, Holder EX, Jones D, et al
    Hypertension, use of antihypertensive medications and breast cancer survival among Black women.
    Breast Cancer Res. 2026 Jun 6. doi: 10.1186/s13058-026-02317.
    PubMed         Abstract available
    
    
17. YANG Y, Lin Y
    Targeting drug resistance in breast cancer: a dual-perspective landscape analysis of PROTACs from bench to bedside.
    Breast Cancer Res. 2026 Jun 9. doi: 10.1186/s13058-026-02320.
    PubMed         Abstract available
    
    
18. VIGNOT S, Drouet Y, Di Meglio A, Martin AL, et al
    Prognostic value of lymphopenia in early breast cancer: learnings from the prospective CANTO cohort.
    Breast Cancer Res. 2026 Jun 9. doi: 10.1186/s13058-026-02315.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

19. FENG X, Deng Z, McCullough MS, May BJ, et al
    Correction: The impact of cardiovascular risk factors on cancer progression: a prospective study in female breast cancer survivors.
    Breast Cancer Res Treat. 2026;217:51.
    PubMed        
    
    
20. HUNDAL J, Cheema A, Abushamma A, Arora K, et al
    Impact of cardiometabolic health on treatment outcomes in early-stage triple-negative breast cancer receiving chemoimmunotherapy.
    Breast Cancer Res Treat. 2026;217:50.
    PubMed         Abstract available
    
    
21. DE LIZ CD, Reis PCA, Blanchard-Cavagis ER, Diniz IC, et al
    Three-monthly gonadotropin-releasing hormone agonist for ovarian function suppression in premenopausal breast cancer: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2026;217:48.
    PubMed         Abstract available
    
    
22. WILSON JM, Rosenberg SM, Crowell KA, Lynch T, et al
    Age-related differences in psychological distress and persistent postsurgical pain after surgery for management of non-invasive breast lesions.
    Breast Cancer Res Treat. 2026;217:47.
    PubMed         Abstract available
    
    
23. DELGADO CASANOVA LB, Dhamne S, Resetkova E, Guirguis MS, et al
    Risk of malignancy after diagnosis of radial sclerosing lesion without atypia.
    Breast Cancer Res Treat. 2026;217:46.
    PubMed         Abstract available
    
    
24. BAYRAKDARIAN S, Hircock C, Wong HCY, Zhang L, et al
    Long-term patient-reported outcomes in a randomized controlled trial of Mepitel Film versus standard of care for the prevention of acute breast radiation dermatitis.
    Breast Cancer Res Treat. 2026;217:44.
    PubMed         Abstract available
    
    

    
    Cancer

25. ARTESE AL, Zhou X, Small BJ, Ahles TA, et al
    Examining bidirectional longitudinal relationships between physical activity and physical function in older breast cancer survivors: The Thinking and Living with Cancer study.
    Cancer. 2026;132:e70366.
    PubMed         Abstract available
    
    
26. BEASLEY HK, Shah T, Tinker RJ, Weidner A, et al
    Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women.
    Cancer. 2026;132:e70402.
    PubMed         Abstract available
    
    

    
    Cancer Cell

27. CRUZ-REYES N, Radisky DC
    When tissue tension creates a mutagenic niche.
    Cancer Cell. 2026;44:1111-1112.
    PubMed         Abstract available
    
    
28. HAYWARD MK, Northey JJ, Opazo-Mellado V, Stashko C, et al
    Tissue tension fosters macrophage-driven lipid peroxidation-induced DNA damage.
    Cancer Cell. 2026;44:1255-1269.
    PubMed         Abstract available
    
    
29. YUAN X, Yu D
    Rethinking immune states in brain metastasis.
    Cancer Cell. 2026;44:1116-1118.
    PubMed         Abstract available
    
    
30. BUI TM, Jimenez ER, Li Z, Foidart P, et al
    Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression.
    Cancer Cell. 2026;44:1179-1200.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

31. NGUYEN AA, Cohen EA, Ehsan S, Mankowski WC, et al
    Longitudinal Association of Quantitative Background Parenchymal Enhancement with Breast Cancer Risk Among Women with BRCA1/2 Pathogenic Variants.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available
    
    

    
    Cancer Lett

32. MA S, Chen M, Sun X, Wei B, et al
    Tamoxifen enhances radiation efficacy by promoting M1 polarization of tumor associated macrophages via JNK/c-JUN pathway.
    Cancer Lett. 2026;655:218609.
    PubMed         Abstract available
    
    
33. LIN LL, Bai JW, Song L, Lou KL, et al
    GSH-Activatable Rare-Earth Nanoprobe for NIR-II Fluorescence Imaging-Guided Surgery and Enhanced Chemotherapy/Chemodynamic Therapy of Breast Cancer.
    Cancer Lett. 2026 Jun 11:218677. doi: 10.1016/j.canlet.2026.218677.
    PubMed         Abstract available
    
    

    
    Cancer Res

34. MAIN SC, Elliott MJ, Singhawansa A, Zou J, et al
    Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.
    Cancer Res. 2026 Jun 10. doi: 10.1158/0008-5472.CAN-26-0076.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

35. VANNI G, Pellicciaro M, Materazzo M, Bertolo A, et al
    Intraoperative Indocyanine Green Angiography as a Predictor of Complications in Breast Cancer Patients Undergoing Conservative Mastectomy.
    Clin Breast Cancer. 2026;26:17-23.
    PubMed         Abstract available
    
    
36. DI LAURO V, Rizzo A, Sacco PC, Palma V, et al
    Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.
    Clin Breast Cancer. 2026;26:10-16.
    PubMed         Abstract available
    
    
37. PRESTES JC, Gouveia AG, da Silva MF, Moraes FY, et al
    Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response.
    Clin Breast Cancer. 2026;26:1-9.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

38. DI GRAZIA G, Di Lauro V, Morchon-Araujo D, Nucera S, et al
    Corrigendum to "Association between chemotherapy use and prognosis in young patients with stage I-II ER+/HER2-negative breast cancer according to Prosigna(R): An international real-world analysis with propensity-score matching" [Eur J Cancer 242 (2026
    Eur J Cancer. 2026;243:116852.
    PubMed        
    
    

    
    Eur J Surg Oncol

39. LUCOCQ J, Karakatsanis A, Kirwan C, Boughey J, et al
    International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer.
    Eur J Surg Oncol. 2026 Apr 15:111791. doi: 10.1016/j.ejso.2026.111791.
    PubMed         Abstract available
    
    

    
    Eur Radiol

40. CHOI JS, Choi N, Chung J, Baek SY, et al
    Comparison of automated breast ultrasound and hand-held breast ultrasound in preoperative evaluation of early-stage breast cancer: a multicenter prospective study.
    Eur Radiol. 2026 Jun 10. doi: 10.1007/s00330-026-12678.
    PubMed         Abstract available
    
    

    
    Histopathology

41. MARABI M, Li Y, Aphivatanasiri C, Tsang JY, et al
    Calcification and tumour-infiltrating lymphocytes predict upgrade of human epidermal growth factor 2 (HER2)-negative ductal carcinoma in situ diagnosed on core needle biopsy.
    Histopathology. 2026;89:122-135.
    PubMed         Abstract available
    
    
42. KOSHY R, Jain PV, Jorns JM
    Characterizing pseudoangiomatous stromal hyperplasia (PASH) of the breast.
    Histopathology. 2026;89:174-180.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

43. DYKSTRA M, Griffith K, Moncion A, Grubb M, et al
    Acute Toxicity and Cosmesis Following a Tumor Bed Boost After Whole Breast Moderate Dose Hypofractionation.
    Int J Radiat Oncol Biol Phys. 2026;125:763-771.
    PubMed         Abstract available
    
    

    
    J Biol Chem

44. SONG H, Lu J, Zhang Y, Lv Z, et al
    FTO Promotes Cancer Progression by Regulating VGLL4 m6A Levels to Activate STAT3 Signaling in Triple-Negative Breast Cancer.
    J Biol Chem. 2026 Jun 9:113242. doi: 10.1016/j.jbc.2026.113242.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

45. BRAUNSTEIN LZ, Mitchell MP, Khan AJ, Sikov WM, et al
    Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies.
    J Clin Oncol. 2026 Jun 8:JCO2502649. doi: 10.1200/JCO-25-02649.
    PubMed        
    
    

    
    J Natl Cancer Inst

46. VAN DUIJNE HM, Berentzen NE, Vermeulen RC, Vlaanderen JJ, et al
    Change in body mass index and physical activity and postmenopausal breast cancer risk in a cohort of Dutch nurses.
    J Natl Cancer Inst. 2026 Jun 5:djag177. doi: 10.1093.
    PubMed         Abstract available
    
    
47. PILEHVARI A, Anderson RT, Shelby R, Kimmick G, et al
    Adjuvant chemotherapy for breast cancer: are all dose reductions inappropriate?
    J Natl Cancer Inst. 2026 Jun 9:djag113. doi: 10.1093.
    PubMed        
    
    

    
    Lancet Oncol

48. BRUNT AM, Cafferty FH, Kirby AM, Patel J, et al
    Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a ran
    Lancet Oncol. 2026;27:686-698.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

49. 
    Editorial Expression of Concern: Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer.
    NPJ Breast Cancer. 2026;12:78.
    PubMed        
    
    
50. ABDELAZIZ MN, Mohamed SOO, Nagi MH, Alawadi IS, et al
    Targeted axillary dissection in breast cancer patients: a systematic review and meta-analysis.
    NPJ Breast Cancer. 2026;12:79.
    PubMed         Abstract available
    
    
51. KAWASHIMA K, Oshi M, Yamada A, Narui K, et al
    The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor status.
    NPJ Breast Cancer. 2026 Jun 6. doi: 10.1038/s41523-026-00981.
    PubMed         Abstract available
    
    
52. BIDARD FC, Barrios C, Bianchini G, Brufsky AM, et al
    SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.
    NPJ Breast Cancer. 2026;12:80.
    PubMed        
    
    

    
    PLoS One

53. EKPO IA, Ovenseri AC, Abdullateef A, Durmaz B, et al
    Formulation of 5-fluorouracil loaded chitosan-based nanoparticles and evaluation of its cytotoxic effects against MCF-7 human breast cancer cells.
    PLoS One. 2026;21:e0350929.
    PubMed         Abstract available
    
    
54. ALAM R, Akter S, Mohammad T, Rini R, et al
    Knowledge of breast cancer and practice of breast self-examination among adolescent girls in semi-urban area - Savar, Dhaka, Bangladesh: A school-based cross-sectional study.
    PLoS One. 2026;21:e0334375.
    PubMed         Abstract available
    
    
55. CHEN S, Yang X, Jiang S, Lin Y, et al
    Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study.
    PLoS One. 2026;21:e0351539.
    PubMed         Abstract available
    
    
56. NDENGUE CP, Atangana PJA, Ateba GR, Mandengue SH, et al
    Pre-analytical variables affecting breast cancer biomarker expression: A controlled single-specimen study of fixation duration, cold ischemia time, and fixative preparation in a low-resource setting.
    PLoS One. 2026;21:e0343185.
    PubMed         Abstract available
    
    
57. EBERLE JV, Bickelhaupt S, Kapsner LA, Ohlmeyer S, et al
    Finite sample size errors in the context of multiple error sources in quantitative medical imaging: An evaluation for breast magnetic resonance diffusion-weighted imaging.
    PLoS One. 2026;21:e0341201.
    PubMed         Abstract available
    
    

    
    Radiology

58. HICKMAN S, Gialias P, Schurz H, Cossio F, et al
    Artificial Intelligence Detection Scores in Screening Mammography for Early Breast Cancer Alerts.
    Radiology. 2026;319:e251309.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum